We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Bone densitometry and bone biopsy.
Bone densitometry is one of the most frequently used investigations in the assessment and management of patients suspected to have osteoporosis. The current method of choice for measuring BMD is dual-energy X-ray absorptiometry, because of its high precision and low radiation dose. The initiation and choice of treatment in patients with osteoporosis is critically dependent on the availability of BMD measurements and BMD can also be used to monitor the response to therapy. Transiliac bone biopsy is indicated for selected patients with metabolic bone disease where less invasive investigations have yielded inconclusive results. Under these circumstances it is an invaluable investigation that can be used to differentiate infiltrative disorders from primary abnormalities of osteoblast or osteoclast function.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app